Congenital Self-Healing Reticulohistiocytosis (Hashimoto–Pritzker Syndrome)

Total Page:16

File Type:pdf, Size:1020Kb

Congenital Self-Healing Reticulohistiocytosis (Hashimoto–Pritzker Syndrome) Journal of Dermatology & Dermatologic Surgery (2014) xxx, xxx–xxx King Saud University Journal of Dermatology & Dermatologic Surgery www.ksu.edu.sa www.jdds.org www.sciencedirect.com CASE REPORT Congenital self-healing reticulohistiocytosis (Hashimoto–Pritzker syndrome) Ali M. Al Ameer *, Abdullah Al Salman, Yosif Al Marzoq, Abdulmohsin Al Hajri, Ibraheem Al Omran, Salha Al Dossari, Mariam Imran Department of Dermatology, King Fahad Hofuf Hospital, Hofuf, Saudi Arabia Received 21 May 2013; revised 3 January 2014; accepted 18 March 2014 KEYWORDS Abstract A case of congenital self-healing reticulohistiocytosis in an otherwise healthy newborn Congenital; boy is presented. Erythematous papules covered by scales on the groin and single nodule on the left Reticulohistiocytosis; side of the forehead, which disappeared spontaneously within four months. Clinical features, histo- Erythematous papules; logical and immunohistochemical findings are described. Up to our knowledge this is the first case Scales; described in Saudi Arabia. Nodule; ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University. Immunohistochemical 1. Case report Liver-spleen scan and bone marrow biopsy were done without any evidence of systemic involvement. The skin lesions had dis- Full term male newborn, a product of Normal Vaginal Delivery, appeared spontaneously within four months. Follow-up for the primigravida and consanguineous marriage presented with ery- baby for six month period revealed no evidence of any relapse. thematous papules covered by scales on the groin (Fig. 1) and The diagnosis of congenital self-healing reticulohistiocytosis single nodule on the left side of the forehead (Fig. 2). Skin biopsy (Hashimoto–Pritzker syndrome) was considered based upon examination revealed large mononuclear cells and multinucle- histopathogical findings along with clinical correlation. ated giant cells with ground-glass or foamy cytoplasm present in the dermis and epidermis (Figs. 3 and 4). Immunoperoxidase 2. Discussion staining was positive for CD1 and S-100. Electron microscopic study showed Langerhans cell granules (Fig. 5). Physical Congenital self-healing reticulohistiocytosis (CSHLCH) or examination revealed no lymphadenopathy, no organomegaly, (Hashimoto–Pritzker syndrome) represents a special form of complete blood count, liver function tests, and bone survey. purely cutaneous Langerhans cell histiocytosis, first described in 1973. This clinical entity is usually present at birth or appears very soon thereafter. Affected infants are otherwise healthy and * Corresponding author. E-mail address: [email protected] (A.M. Al Ameer). skin lesions tend to involute spontaneously within weeks to Peer review under responsibility of King Saud University. months. The diagnosis of LCH is based on histopathology which is indistinguishable for all forms of LCH. Characteristic histopathology and absence of other system involvement permit differentiation of benign forms of LCH. The diagnosis of Production and hosting by Elsevier CSHLCH should be made only retrospectively, after exclusion http://dx.doi.org/10.1016/j.jdds.2014.03.002 2352-2410 ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University. Please cite this article in press as: Al Ameer, A.M. et al., Congenital self-healing reticulohistiocytosis (Hashimoto–Pritzker syndrome). Journalof Dermatology & Dermatologic Surgery (2014), http://dx.doi.org/10.1016/j.jdds.2014.03.002 2 A.M. Al Ameer et al. Figure 1 Erythematous papules covered by scales on the groin. Figure 4 High power large mononuclear cells and multinucle- ated giant cells with ground-glass or foamy cytoplasm present in the dermis and epidermis. Figure 2 Single nodule on the left side of the forehead. of involvement of other organs/systems (Popadic et al., 2012). It has been described in two forms: a solitary and a multinodular variant. Solitary or generalized lesions can affect any part of the cutaneous surface. Lesions range from 0.2 to 2.5 cm in diam- Figure 5 Electron microscopic study showed Langerhans cell eter. Lesions may grow postnatally. Exceptionally large tumors granules. up to 8 cm can occur (Alexis et al., 1991). At presentation the lesions can be papules or nodules with or without erosion or ulceration. Individual lesions are red, brown, pink, or dusky. Histiocytosis has been reported in Saudi Arabia, a retro- Lesions greater than 1 cm characteristically ulcerate as they spective analysis of 21 Saudi children with Histiocytosis-X resolve. Lesions are asymptomatic and spontaneously involute was reviewed and follow-up from 1 to 10 years revealed bone over 8–24 weeks, leaving atrophic scarring from the ulcerated involvement in 19 patients and three patients died, three had nodules. Internal involvement is not found (Anon., 2011). recurrences and eight had other organ dysfunction (Al- Molhim et al., 1991). However in our case there were no sys- temic involvement and the disease was confined to the skin. According to the data collected by Belhadjali et al., CSHLCH may be divided into two groups, the first group with skin lesions appeared at birth as observed in our case, and the second group with later onset (Belhadjali et al., 2008). Estimated incidence of LCH is 2.24–8.9 cases/one million/year among European children (Mu¨ller et al., 2006; Stalemark et al., 2008). The real incidence of self healing LCH is unknown and may be underestimated due to the spontaneous resolution and failure of clinical recognition (Kapur et al., 2007). The etiopathogenesis of reticulohistiocytosis is unknown, but the possibility of an immunological etiology has been sug- gested by the occurrence of a number of immunological abnor- malities in this disease. The fact that the lesional cell bears the phenotype of the Langerhans cell, which is a key cell in the Figure 3 Low power large mononuclear cells and multinucleated immune system also suggests that the immune system is in giant cells with ground-glass or foamy cytoplasm present in the some way involved in its pathogenesis. None of the immuno- dermis and epidermis. logical abnormalities, however, have been a consistent feature, Please cite this article in press as: Al Ameer, A.M. et al., Congenital self-healing reticulohistiocytosis (Hashimoto–Pritzker syndrome). Journalof Dermatology & Dermatologic Surgery (2014), http://dx.doi.org/10.1016/j.jdds.2014.03.002 Congenital self-healing reticulohistiocytosis 3 and most authors now consider them to be epiphenomena References (Cunliffe and Simpson, 2010). On histologic examination large mononuclear cells and Alexis, J.B., Poppiti, R.J., Turbat-Herrera, E., Smith, M.D., 1991. multinucleated giant cells with ground-glass or foamy cyto- Congenital self-healing reticulohistiocytosis. Report of a case with plasm are present in the dermis and epidermis. Immunoperox- 7-year follow-up and a review of the literature. Am. J. Dermato- idase staining is positive for CD1, HLA-DR, and S-100. By pathol. 13 (2), 189–194. electron microscopy 10%–25% of cells have Langerhans cell Al-Molhim, I., Sabbah, R.S., Al Akkad, S., 1991. Indian J. Cancer 28 granules. This histology is characteristic but cannot distinguish (2), 53–60. Belhadjali, H., Mohamed, M., Mahmoudi, H., Youssef, M., Moussa, this entity from other forms of Langerhans cell histiocytosis, A., Chouchane, S., et al, 2008. Self-healing Langerhans cell so a definitive diagnosis cannot be made histologically histiocytosis (Hashimoto-Pritzker disease): two Tunisian cases. (Gadner and Grois, 1999). Acta Dermatovenerol. Alp. Panonica Adriat. 17, 188–192. Systemic evaluation is recommended, including a physical Cunliffe, W.J., Simpson, N.B., 2010. Disorders of the sebaceous examination, complete blood count, liver function tests, and glands. In: Rook, Wilkinson, Ebling (Eds.), Text Book of Derma- bone survey. Liver-spleen scan and bone marrow biopsy tology, eight ed. Blackwell Scientific Publications, Oxford. should be considered to rule out systemic involvement Elguezabal, A., Ture´gano, P., Landeyro, J., Mayayo, E., 2011. Solitary (Gadner and Grois, 1999). congenital self-healing histiocytosis (Hashimoto-Pritzker disease). The differential diagnosis includes seborrhoeic dermatitis, Actas Dermosifiliogr. 102 (4), 301–303. http://dx.doi.org/10.1016/ juvenile xanthogranuloma, xanthoma disseminatum, and j.ad.2010.07.007 (Epub 2011 Feb 22). Gadner, H., Grois, N., 1999. The histiocytosis syndromes. In: benign cephalic histiocytosis. In disseminated Langerhans cell Fitzpatrick, T.B., Eisen, A.L., Wolff, K., Freedberg, I.M., Austen, histiocytosis there may be diagnostic problems with familial K.F. (Eds.), Dermatology in General Medicine, fifth ed. McGraw hemophagocytic lymphohistiocytosis, sinus histiocytosis with Hill, New York, pp. 2003–2016. massive lymphadenopathy, and viral-associated hemophago- Kapur, P., Erickson, C., Rakheja, D., Carder, K.R., Hoang, M.P., cytic syndrome. Histological examination of tissue biopsy with 2007. Congenital self-healing reticulohistiocytosis (Hashimoto- specific marker studies is usually sufficient to differentiate Lan- Pritzker disease): ten-year experience at Dallas Children’s Medical gerhans cell histiocytosis from other conditions (Odom et al., Center. J. Am. Acad. Dermatol. 56, 290–294. 2000). McLelland, J., Broadbent, V., Yeoman, E., et al, 1990. Langerhans Treatment depends on the extent and the severity of the dis- cell histiocytosis; A conservative approach to treatment. Arch. Dis. ease. Patients with single-system bone or skin disease have a Child. 65, 301–303.
Recommended publications
  • Cutaneous Neonatal Langerhans Cell Histiocytosis
    F1000Research 2019, 8:13 Last updated: 18 SEP 2019 SYSTEMATIC REVIEW Cutaneous neonatal Langerhans cell histiocytosis: a systematic review of case reports [version 1; peer review: 1 approved with reservations, 1 not approved] Victoria Venning 1, Evelyn Yhao2,3, Elizabeth Huynh2,3, John W. Frew 2,4 1Prince of Wales Hospital, Randwick, Sydney, NSW, 2033, Australia 2University of New South Wales, Sydney, NSW, 2033, Australia 3Sydney Children's Hospital, Randwick, NSW, 2033, Australia 4Department of Dermatology, Liverpool Hospital, Sydney, Sydney, NSW, 2170, Australia First published: 03 Jan 2019, 8:13 ( Open Peer Review v1 https://doi.org/10.12688/f1000research.17664.1) Latest published: 03 Jan 2019, 8:13 ( https://doi.org/10.12688/f1000research.17664.1) Reviewer Status Abstract Invited Reviewers Background: Cutaneous langerhans cell histiocytosis (LCH) is a rare 1 2 disorder characterized by proliferation of cells with phenotypical characteristics of Langerhans cells. Although some cases spontaneously version 1 resolve, no consistent variables have been identified that predict which published report report cases will manifest with systemic disease later in childhood. 03 Jan 2019 Methods: A systematic review (Pubmed, Embase, Cochrane database and all published abstracts from 1946-2018) was undertaken to collate all reported cases of cutaneous LCH in the international literature. This study 1 Jolie Krooks , Florida Atlantic University, was registered with PROSPERO (CRD42016051952). Descriptive statistics Boca Raton, USA and correlation analyses were undertaken. Bias was analyzed according to Milen Minkov , Teaching Hospital of the GRADE criteria. Medical University of Vienna, Vienna, Austria Results: A total of 83 articles encompassing 128 cases of cutaneous LCH were identified.
    [Show full text]
  • Case Report Congenital Self-Healing Reticulohistiocytosis
    Case Report Congenital Self-Healing Reticulohistiocytosis Presented with Multiple Hypopigmented Flat-Topped Papules: A Case Report and Review of Literatures Rawipan Uaratanawong MD*, Tanawatt Kootiratrakarn MD, PhD*, Poonnawis Sudtikoonaseth MD*, Atjima Issara MD**, Pinnaree Kattipathanapong MD* * Institute of Dermatology, Department of Medical Services Ministry of Public Health, Bangkok, Thailand ** Department of Pediatrics, Saraburi Hospital, Sabaruri, Thailand Congenital self-healing reticulohistiocytosis, also known as Hashimoto-Pritzker disease, is a single system Langerhans cell histiocytosis that typically presents in healthy newborns and spontaneously regresses. In the present report, we described a 2-month-old Thai female newborn with multiple hypopigmented flat-topped papules without any internal organ involvement including normal blood cell count, urinary examination, liver and renal functions, bone scan, chest X-ray, abdominal ultrasound, and bone marrow biopsy. The histopathology revealed typical findings of Langerhans cell histiocytosis, which was confirmed by the immunohistochemical staining CD1a and S100. Our patient’s lesions had spontaneously regressed within a few months, and no new lesion recurred after four months follow-up. Keywords: Congenital self-healing reticulohistiocytosis, Congenital self-healing Langerhans cell histiocytosis, Langerhans cell histiocytosis, Hashimoto-Pritzker disease, Birbeck granules J Med Assoc Thai 2014; 97 (9): 993-7 Full text. e-Journal: http://www.jmatonline.com Langerhans cell histiocytosis (LCH) is a multiple hypopigmented flat-topped papules, which clonal proliferative disease of Langerhans cell is a rare manifestation. involving multiple organs, including skin, which is the second most commonly involved organ by following Case Report the skeletal system(1). LCH has heterogeneous clinical A 2-month-old Thai female infant presented manifestations, ranging from benign single system with multiple hypopigmented flat-topped papules since disease to fatal multisystem disease(1-3).
    [Show full text]
  • Congenital Self-Healing Reticulohistiocytosis: an Underreported Entity
    Congenital Self-healing Reticulohistiocytosis: An Underreported Entity Michael Kassardjian, DO; Mayha Patel, DO; Paul Shitabata, MD; David Horowitz, DO PRACTICE POINTS • Langerhans cell histiocytosis (LCH) is believed to occur in 1:200,000 children and tends to be underdiagnosed, as some patients may have no symptoms while others have symptoms that are misdiagnosed as other conditions. • Patients with L CH usually should have long-term follow-up care to detect progression or complications of the disease or treatment. copy not Langerhans cell histiocytosis (LCH), also known angerhans cell histiocytosis (LCH), also as histiocytosis X, is a group of rare disorders known as histiocytosis X, is a general term that characterized by the continuous replication of describes a group of rare disorders characterized L 1 a particular white blood cell called LangerhansDo by the proliferation of Langerhans cells. Central cells. These cells are derived from the bone mar- to immune surveillance and the elimination of for- row and are found in the epidermis, playing a large eign substances from the body, Langerhans cells are role in immune surveillance and the elimination of derived from bone marrow progenitor cells and found foreign substances from the body. Additionally, in the epidermis but are capable of migrating from Langerhans cells are capable of migrating from the the skin to the lymph nodes. In LCH, these cells skin to lymph nodes, and in LCH, these cells begin congregate on bone tissue, particularly in the head to congregate on the bone, particularly in the head and neck region, causing a multitude of problems.2 and neck region, causingCUTIS a multitude of problems.
    [Show full text]
  • Congenital Self-Healing Reticulohistiocytosis in a Newborn
    Rizzoli et al. Italian Journal of Pediatrics (2021) 47:135 https://doi.org/10.1186/s13052-021-01082-9 CASE REPORT Open Access Congenital self-healing reticulohistiocytosis in a newborn: unusual oral and cutaneous manifestations Alessandra Rizzoli1, Simona Giancristoforo2* , Cristina Haass1, Rita De Vito3, Stefania Gaspari4, Eleonora Scapillati1, Andrea Diociaiuti2 and May El Hachem2 Abstract Background: Congenital self-healing reticulohistiocytosis (CSHRH), also called Hashimoto-Pritzker disease, is a rare and benign variant of Langerhans cell histiocytosis, characterized by cutaneous lesions without extracutaneous involvement. Case presentation: We present a case of CSHRH with diffuse skin lesions and erosions in the oral mucosa, present since birth and lasting for 2 months, and we perform a review of the literature on Pubmed in the last 10 years. Conclusions: Our case confirm that lesions on oral mucosa, actually underestimated, may be present in patients with CSHRH. Patients affected by CSHRH require a close follow-up until the first years of life, due to the unpredictable course of Langerhans cell histiocytosis, in order to avoid missing diagnosis of more aggressive types of this disorder. Keywords: Congenital self-healing reticulohistiocytosis, CSHRH, Hashimoto-Pritzker disease, Histiocytosis, Newborn Background We report a case of a newborn with cutaneous and Congenital self-healing reticulohistiocytosis (CSHRH), oral mucosa involvement. In addition, a review of the lit- also known as Hashimoto-Pritzker disease, is a rare be- erature was perfomed on Pubmed using the following nign type of Langerhans cell histiocytosis (LCH) de- mesh terms: “Congenital self-healing reticulohistiocyto- scribed in 1973 [1, 2]. sis”, “congenital self-healing Langerhans cell histiocyto- CSHRH manifests generally at birth or during the neo- sis” and “Hashimoto-Pritzker disease”.
    [Show full text]
  • Long-Lasting Christmas Tree Rash" in an Adolescent: Isotopic Response
    Acta Derm Venereol 2002; 82: 288–291 CLINICAL REPORT Long-lasting ``Christmas Tree Rash’’ in an Adolescent: Isotopic Response of Indeterminate Cell Histiocytosis in Pityriasis Rosea? ANDREAS WOLLENBERG, WALTER H. C. BURGDORF, MARTIN SCHALLER and CHRISTIAN SANDER Department of Dermatology and Allergy, Ludwig-Maximilian-University, Munich, Germany A 13-year-old girl developed a non-pruritic pityriasis rosea, followed by other, smaller red macules on her rosea-like rash, which did not respond to topical cortico- trunk (Fig. 1). After 6 months, all individual lesions steroids or UV therapy but persisted for 2 years. The had persisted, grew slowly in size and became in part lymphohistiocytic in ltrate in the upper dermis showed con uent, but neither itched nor caused any distress. A mononuclear cells immunoreactive with S100, CD68, biopsy showed parakeratosis, extravascular and intraepi- factor XIIIa and CD1a. Electron microscopic evaluation dermal erythrocytes and spongiosis, more suggestive of of these cells demonstrated lamellated dense bodies but pityriasis lichenoides but compatible with pityriasis no Birbeck granules, lipid vacuoles or cholesterol crystals. rosea. Over the following 18 months, the lesions Two diagnoses were made: a primarily clinical diagnosis increased further in number and size. Topical cortico- of generalized eruptive histiocytosis and a more cell- steroids and balneophototherapy were ineVective. biology-based diagnosis of an indeterminate cell histi- At 15 years of age, the patient was admitted to ocytosis. Three years later, the lesions are showing spon- hospital with about 500, round to oval, con uent, taneous resolution, with loss of erythema and attening. in ltrated, reddish-brown macules and plaques ranging Our patient’s indeterminate cells ful l Rowden’s clas- in size from 5 to 30 mm in a Christmas tree pattern on sical de nition (dendritically shaped epidermal non- the trunk, upper arms and legs (Fig.
    [Show full text]
  • Unusual Variants of Non-Langerhans Cell Histiocytoses
    REVIEWS Unusual variants of non-Langerhans cell histiocytoses Ruggero Caputo, MD,a Angelo Valerio Marzano, MD,a Emanuela Passoni, MD,a and Emilio Berti, MDb Milan, Italy Histiocytic syndromes represent a large, heterogeneous group of diseases resulting from proliferation of histiocytes. In addition to the classic variants, the subset of non-Langerhans cell histiocytoses comprises rare entities that have more recently been described. These last include both forms that affect only the skin or the skin and mucous membranes, and usually show a benign clinical behavior, and forms involving also internal organs, which may follow an aggressive course. The goal of this review is to outline the clinical, histologic, and ultrastructural features and the course, prognosis, and management of these unusual histiocytic syndromes. ( J Am Acad Dermatol 2007;57:1031-45.) istiocytic syndromes represent a large, puzzling group of diseases resulting from Abbreviations used: proliferation of cells called histiocytes.1 BCH: benign cephalic histiocytosis H ECD: Erdheim-Chester disease The term ‘‘histiocyte’’ includes cells of both the GEH: generalized eruptive histiocytosis monocyte-macrophage series and the Langerhans HPMH: hereditary progressive mucinous cell (LC) series, both antigen-processing and anti- histiocytosis 1 IC: indeterminate cell gen-presenting cells deriving from CD34 progeni- ICH: indeterminate cell histiocytosis tor cells in the bone marrow. JXG: juvenile xanthogranuloma In 1987, the Histiocyte Society proposed a classi- LC: Langerhans cell LCH: Langerhans cell histiocytoses fication of histiocytic syndromes based on 3 classes: MR: multicentric reticulohistiocytosis (1) class I, corresponding to LC histiocytoses (LCH); PNH: progressive nodular histiocytosis (2) class II, encompassing the histiocytoses of mon- PX: papular xanthoma onuclear phagocytes other than LC (non-LCH); and SBH: sea-blue histiocyte 2 SBHS: sea-blue histiocytic syndrome (3) class III, comprising the malignant histiocytoses.
    [Show full text]
  • A Case of Generalized Eruptive Histiocytosis
    Acta Derm Venereol 2007; 87: 533–536 CLINICAL REPORT A Case of Generalized Eruptive Histiocytosis Beatriz FERNÁNDEZ-JORGE1, Jaime GODAY-BUJÁN1, Jesús DEL POZO LOSADA1, Roberto ÁlvaREZ-RODRÍGUEZ2 and Eduardo FONSECA Departments of 1Dermatology and 2Pathology, Hospital Juan Canalejo, A Coruña, Spain Histiocytoses are a heterogeneous group of diseases, proliferation of benign histiocytes without deposition of characterized by the accumulation of reactive or neo­ lipids, iron or mucine. Electron microscopy reveals that plastic histiocytes in various tissues. Generalized erup­ these cells may possess various markers, such as comma- tive histiocytosis belongs to cutaneous non­Langerhans’ shaped bodies, dense bodies and regularly laminated cell histiocytoses and is a rare, generalized, self­healing bodies, but no Birbeck granules. Herein we report a case disorder that usually follows a benign clinical course. of GEH in a 41-year-old woman with peculiar clinical Herein, we report a case of generalized eruptive histio­ and immunohistochemical features. cytosis in a 41­year­old woman with peculiar clinical and histological features. Clinically, the papules showed a marked distribution into the seborrhoeic areas of the Case REPORT trunk, with a great tendency to coalesce. Furthermore, A 41-year-old woman presented with a 3-month history immunohistochemical labelling demonstrated that the of progressive appearance of brown to reddish and histiocytes were positive for CD68, but negative for slightly elevated macules and papules, symmetrically CD34, S100, CD1a and XIIIa factor. This is the second distributed on the seborrhoeic areas of the trunk and report of generalized eruptive histiocytosis with a nega­ extensor surface of both upper arms (Figs 1 and 2).
    [Show full text]
  • Langerhans Cell Histiocytosis Nanette Grana, MD
    LCH is a rare and often underdiagnosed histiocytic disorder with an unknown etiology. White Butterfly. Photograph courtesy of Sherri Damlo. www.damloedits.com. Langerhans Cell Histiocytosis Nanette Grana, MD Background: Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder of unknown etiopathogenesis. Its clinical presentation is variable and ranges from isolated skin or bone disease to a life-threatening multisystem condition. LCH can occur at any age but is more frequent in the pediatric population. A neoplastic origin of this disease has been suggested due to the discovery of the mutually exclusive activating somatic BRAF V600E and MAP2K1 gene mutations that occur in about 75% of patients. Methods: A survey of recent literature focused on the diagnosis, management, and prognosis of Langerhans cell histiocytosis. Data were collected, analyzed, and discussed with an emphasis on contemporary clinical practice. Results: LCH is common in the pediatric population; compared with adults, children usually have a more aggressive clinical course that requires systemic chemotherapy. Patients with low-risk LCH have an excellent prognosis and a long-term survival rate that may be as high as 99%; by contrast, patients with high-risk LCH have a survival rate close to 80%. Typically, adult patients present with limited skin or bone involvement that can be treated with surgical resection or focal radiation therapy, resulting in an overall survival rate of 100%. Smoking cessation can result in the improvement of respiratory symptoms and the spontaneous resolution of pulmonary LCH. Targeted therapy with BRAF inhibitors has been used in select patients with LCH, and the results have been encouraging.
    [Show full text]
  • Presenters: Philip R
    Volume 20 Number 3 March 2014 Case Report Adult-onset reticulohistiocytoma presenting as a solitary asymptomatic red knee nodule: report and review of clinical presentations and immunohistochemistry staining features of reticulohistiocytosis Philip R. Cohen MD and Robert A. Lee MD PhD Dermatology Online Journal 20 (3): 3 Division of Dermatology, University of California San Diego, San Diego, California. Correspondence: Philip R. Cohen, MD 10991 Twinleaf Court San Diego, CA 92131-3643 [email protected] Abstract Reticulohistiocytomas are benign dermal tumors that usually present as either solitary or multiple, cutaneous nodules. Reticulohistiocytosis can present as solitary or generalized skin tumors or cutaneous lesions with systemic involvement and are potentially associated with internal malignancy. A woman with a solitary red nodule on her knee is described in whom the clinical differential diagnosis included dermatofibroma and amelanotic malignant melanoma. Hematoxylin and eosin staining and immunoperoxidase studies of the biopsy specimen established the diagnosis of adult-onset reticulohistiocytoma (solitary epithelioid histiocytoma). Reticulohistiocytoma is characterized by mononuclear, and occasionally multinuclear, histiocytes with eosinophilic “glassy” cytoplasm. The immunohistochemical profile of a reticulohistiocytoma demonstrates consistent positive expression for CD68 (a marker that is expressed by histiocytes but can also show positive staining in melanomas and carcinomas), CD163 (a very specific marker for histiocytes),
    [Show full text]
  • Congenital Self-Healing Reticulohistiocytosis: a Case Report
    Case Report DOI: 10.7241/ourd.20143.66 CONGENITAL SELF-HEALING RETICULOHISTIOCYTOSIS: A CASE REPORT Shricharith Shetty1, Vidya Monappa2, Kanthilatha Pai2, Raghavendra Rao1, Sathish Pai1 1Department of Dermatology, Kasturba Medical College, Manipal University, Manipal, Karnataka, India 2Department of Pathology, Kasturba Medical College, Manipal University, Manipal, Source of Support: Karnataka, India Nil Competing Interests: None Corresponding author: Dr. Kanthilatha Pai [email protected] Our Dermatol Online. 2014; 5(3): 264-266 Date of submission: 27.04.2014 / acceptance: 30.05.2014 Abstract Congenital self-healing reticulohistiocytosis (CSHRH) is a benign type of Langerhans cell histiocytosis (LCH) also known as Hashimoto- Pritzker disease. Clinically it presents with skin lesions at birth or in neonatal period, usually without any systemic involvement. Lesions often heal spontaneously in period of weeks to months. We report a case of CSHRH presenting with skin lesions at birth, describing need to make an early diagnosis and to have a multidisciplinary approach with regular follow-up, in managing this rare type of LCH. Key words: Congenital; reticulohistiocytosis; Langerhans cell histiocytosis Cite this article: Shetty S, Monappa V, Pai K, Rao R, Pai S. Congenital self-healing reticulohistiocytosis: a case report. Our Dermatol Online. 2014; 5(3): 264-266. Introduction and APGAR score, presented with reddish brown papules all Langerhans cell histiocytosis (LCH) is a clonal proliferative over the body, progressively developing since birth. Lesions disease of Langerhans cells with broad spectrum of forms. were predominantly present on trunk, distributed on face, It can be local asymptomatic form with indolent course or upper and lower limbs (Fig.1). Lesions heal leaving behind symptomatic form involving multiple organs.
    [Show full text]
  • MEETING REPORT Updates on Histiocytic Disorders
    Pediatr Blood Cancer 2014;61:1329–1335 MEETING REPORT Updates on Histiocytic Disorders 1 y 2z 3# 4,5§ Sarah R. Vaiselbuh, MD, * Yenan T. Bryceson, PhD, MS, Carl E. Allen, MD, PhD, James A. Whitlock, MD, 4§ and Oussama Abla, MD Histiocytic disorders are rare entities that are becoming more and Rosai Dorfman disease (RDD) including subsections on recognized as our understanding of the molecular pathogenesis lead pathogenesis, clinical diagnostic criteria and novel insights into to novel diagnostic tests and targeted drug development. A treatment. Details of other histiocytic disorders as well as the symposium held at the American Society of Pediatric Hematology/ standard treatment guidelines have been published elsewhere and Oncology (ASPHO) 2013 Annual Meeting discussed new insights are beyond the scope of this discussion [Haupt et al. (2013). Pediatr into histiocytic disorders. This review highlights the symposium Blood Cancer 60:175–184; Henter et al. (2007). Pediatr Blood presentations, divided into three sections encompassing Langerhans Cancer 2014;61:1329–1335. # 2014 Wiley Periodicals, Inc. cell histiocytosis (LCH), hemophagocytic lymphohistiocytosis (HLH) Key words: hemophagocytic lymphohistiocytosis; Langerhans cell histiocytosis; Rosai Dorfman disease; targeted therapies INTRODUCTION frequency ranging from 38% to 57% [8–12]. A novel somatic mutation in BRAF and germline variants of (T599A) BRAF have Histiocytoses describe a diverse group of proliferative disorders also been described in patients with LCH, though the significance of involving dentritic cells and macrophages. They include a spectrum these observations remains to be defined [10–12]. The frequency of of diseases including a reactive inflammatory accumulation of cells, the somatic BRAF-V600E mutation implies functional significance pathologic immune activation, or neoplastic clonal proliferation.
    [Show full text]
  • UC Davis Dermatology Online Journal
    UC Davis Dermatology Online Journal Title Generalized eruptive histiocytosis associated with a novel fusion in LMNA-NTRK1 Permalink https://escholarship.org/uc/item/07d3f2xk Journal Dermatology Online Journal, 22(8) Authors Pinney, Sarah S Jahan-Tigh, Richard R Chon, Susan Publication Date 2016 DOI 10.5070/D3228032091 License https://creativecommons.org/licenses/by-nc-nd/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Volume 22 Number 8 August 2016 Case Report Generalized eruptive histiocytosis associated with a novel fusion in LMNA-NTRK1 Sarah S. Pinney1 MD, Richard R. Jahan-Tigh1 MD, Susan Chon2 MD Dermatology Online Journal 22 (8): 4 1. University of Texas Health Sciences Center at Houston-UT Health, Dept. of Dermatology 2. M.D. Anderson Cancer Center, Dept. of Dermatology, Houston, TX. Correspondence: Sarah A. Sweeney 6655 Travis Street, Suite 980 Houston, TX Tel. 713-500-8329 FAX. 713-500-8321 EMAIL: [email protected] Abstract Non-Langerhans cell histiocytosis (NLCH) is a histiocyte disorder comprised of dermal dendritic histiocytes with a characteristic staining pattern. Erdheim-Chester disease (ECD) is a subset of NLCH in which patients experience bone pain with corresponding changes on imaging. In addition, these patients show other evidence of systemic involvement, which can also be identified with imaging. This disease can occasionally present with cutaneous findings. We present a case of generalized eruptive histiocytosis (GEH), misdiagnosed as ECD, found to have an NTRK1 gene rearrangement. This is the first report of an NTRK1 kinase fusion with NLCH. The implication is unclear and further studies are warranted.
    [Show full text]